Blopress Under Attack In Japan Generic Listing
This article was originally published in PharmAsia News
Executive Summary
Japan has listed in the national insurance reimbursement tariff its latest batch of generic drugs, awarding prices to 521 products from 72 companies, including versions of Takeda's blockbuster antihypertensive Blopress.